Nvidia Gains After $20B Groq Licensing Deal for Inference AI

Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell

  • Stocks rose midday Friday as U.S. markets reopened after the Christmas holiday, with the S&P 500 hitting a fresh high.
  • NVIDIA agreed to a non‑exclusive licensing deal for its inference technology valued at about $20 billion, lifting its shares nearly 2%.
  • Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell all saw notable gains after company‑specific news.

U.S. equities traded higher midday Friday as investors returned after the Christmas holiday and the S&P 500 notched a new all‑time high. Markets showed modest ETF gains: the SPDR S&P 500 ETF (SPY) rose 0.08%, the Invesco QQQ Trust (QQQ) gained 0.16%, and the SPDR Dow Jones Industrial Average ETF Trust (DIA) climbed 0.01%.

- Advertisement -

Nvidia Corp. shares rose nearly 2% after the company entered a non‑exclusive licensing agreement with Groq for its inference technology, a deal valued at about $20 billion. Inference technology is software and models that run trained artificial‑intelligence systems to produce outputs from input data.

Sidus Space Inc. jumped more than 22% midday after the firm was awarded a contract under the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program. SIDU stock has climbed about 237% over the past five trading sessions.

According to Reuters, Coupang Inc. rose over 9% after the company said that “all leaked customer information has been deleted”; Coupang stated the suspect was a former employee. CPNG is up roughly 10% over the past five trading sessions.

Vanda Pharmaceuticals Inc. gained nearly 8% in premarket trading before settling about 3% higher as investors awaited an upcoming U.S. Food and Drug Administration decision on Tradipitant, a motion‑sickness prevention drug. VNDA is up 7% over five sessions.

- Advertisement -

ImmuCell Corp. rose nearly 10% midday after announcing a 50% expansion of its First Defense field sales force and plans to scale up drug manufacturing; the company also said it is pausing its Re‑Tain treatment for cows after receiving an “Incomplete Letter” from the FDA. ICCC is up about 2% over the past five trading sessions.

✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.

Previous Articles:

- Advertisement -

Latest News

Silver’s rally reignites debate: Bitcoin vs. precious metals

Silver reached a record spot price near $94 per ounce on Monday.Gold climbed to...

Satoshi-era 909 BTC wallet wakes after 13 years, moves $85M.

A Satoshi‑era wallet transferred its full balance of 909.38 BTC—about $84.6 million—after 13 years...

Cardano Volatility Fuels Comeback Hopes After Hoskinson Buzz

Cardano (ADA) trades at $0.36, up 2% in the last 24 hours, after sharp...

Ethereum Leads Bitcoin Liquidations as Macro Headwinds Bite.

Ethereum led crypto liquidations over the last 24 hours, surpassing Bitcoin.Total crypto liquidations totaled...

Bitcoin Falls Amid US-EU Tariff Fears, Drops Near $92K today

Bitcoin traded near $92,000 on Jan. 19 after a weekend decline tied to concerns...
- Advertisement -

Must Read

12 Hosting Providers To Buy VPS With Bitcoin: An Expert Guide for 2026

You need a VPS. You want to pay with Bitcoin. Simple enough, right?Not quite. The market for crypto VPS = VPS hosting that accepts...
Bitcoin (BTC) $ 90,783.00 2.57%
Ethereum (ETH) $ 3,091.26 3.75%
XRP (XRP) $ 1.92 2.66%
Bittensor (TAO) $ 239.83 4.41%
Polkadot (DOT) $ 1.98 0.82%
Cardano (ADA) $ 0.358822 2.35%
Chainlink (LINK) $ 12.50 2.49%
Hyperliquid (HYPE) $ 23.01 4.57%
Monero (XMR) $ 584.27 7.85%
Hedera (HBAR) $ 0.107071 2.82%
Toncoin (TON) $ 1.56 3.90%